MedPath

Amderma

🇷🇺Russia
Ownership
Private
Established
1933-01-01
Employees
-
Market Cap
-
Website
http://amderma.ru

Clinical Trials

7

Active:0
Completed:7

Trial Phases

2 Phases

Phase 2:5
Phase 3:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials

Phase 2
5 (71.4%)
Phase 3
2 (28.6%)

Safety and Efficacy Study of AM001 Cream in the Treatment of Actinic Keratosis

Phase 2
Completed
Conditions
Actinic Keratosis
Interventions
Drug: AM001 Cream, 7.5%
Drug: Vehicle Cream
First Posted Date
2017-07-07
Last Posted Date
2019-04-30
Lead Sponsor
AmDerma
Target Recruit Count
30
Registration Number
NCT03210740
Locations
🇺🇸

AmDerma Pharmaceuticals, LLC, High Point, North Carolina, United States

Safety and Efficacy Study Comparing AM001 Cream, 7.5% to Vehicle Cream in the Treatment of Plaque Psoriasis

Phase 2
Completed
Conditions
Plaque Psoriasis
Interventions
Drug: AM001 Cream, 7.5%
Drug: Vehicle Cream
First Posted Date
2016-12-30
Last Posted Date
2018-10-03
Lead Sponsor
AmDerma
Target Recruit Count
74
Registration Number
NCT03005964
Locations
🇩🇴

Instituto Dermatogical y Cirugia de Piel, San Cristobal, Dominican Republic

🇩🇴

Instituto Dermatologico Blanco Falette, MD, Santo Domingo, Dominican Republic

Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis

Phase 2
Completed
Conditions
Plaque Psoriasis
Skin Diseases, Papulosquamous
Skin Diseases
Interventions
Drug: AM001 Cream, 7.5%
Drug: Placebo of AM001 Cream
First Posted Date
2013-09-10
Last Posted Date
2016-12-01
Lead Sponsor
AmDerma
Target Recruit Count
92
Registration Number
NCT01938599
Locations
🇺🇸

International Dermatology Research, Inc., Miami, Florida, United States

🇺🇸

Minnesota Clinical Study Center, Fridley, Minnesota, United States

🇺🇸

Academic Dermatology Association, Albuquerque, New Mexico, United States

and more 2 locations

Comparative PK Study of Econazole Nitrate Foam and Econazole Nitrate Cream in Subjects With Interdigital Tinea Pedis Aged 12 Years to Less Than 18 Years

Phase 2
Completed
Conditions
Interdigital Tinea Pedis
Interventions
First Posted Date
2012-10-01
Last Posted Date
2012-10-01
Lead Sponsor
AmDerma
Target Recruit Count
42
Registration Number
NCT01696799
Locations
🇺🇸

Therapeutics Inc., San Diego, California, United States

Safety and Efficacy of Econazole Nitrate Foam 1% and Foam Vehicle in Subjects With Tinea Pedis

Phase 3
Completed
Conditions
Tinea Pedis
Athlete's Foot
Interventions
First Posted Date
2011-05-23
Last Posted Date
2012-09-28
Lead Sponsor
AmDerma
Target Recruit Count
336
Registration Number
NCT01358240
Locations
🇺🇸

Sunil S. Dhawan, MD, Fremont, California, United States

🇺🇸

Guy F. Webster, MD, PhD, Hockessin, Delaware, United States

🇺🇸

Marta I. Rendon, MD, Boca Raton, Florida, United States

and more 9 locations
  • Prev
  • 1
  • 2
  • Next

News

No news found
© Copyright 2025. All Rights Reserved by MedPath